JAB1与糖皮质激素受体的相互作用及对其转录活性的影响

应用酵母双杂交方法筛选到与糖皮质激素受体(GR)结合的蛋白JAB1,进一步验证JAB1与GR的结合作用并证明其对GR的影响.构建与Gal4-BD融合表达的载体pGBKT7-GR LBD,与构建于pACT2载体上的人骨髓cDNA文库杂交,在SD/-Ade/-His/-Leu/-Trp选择培养板上培养,经X-α-gal检测,阳性克隆片段插入pGEM^®-T Vector 载体,测序,再经酵母双杂交和GST pull down蛋白质结合实验验证其结合作用,应用反映GR转录活性的CAT报告基因检测JAB1对GR的调节活性.结果在人骨髓cDNA文库中,筛选到42个X-α-gal检测变蓝且含有pACT2质粒序列的克隆,其中有5个克隆的序列皆为Jun活性区结合蛋白JAB1的一部分.酵母双杂交和蛋白质结合实验表明,JAB1与COS7真核表达的GR-LBD在体外有结合作用.JAB1加强GR转录激活的能力.     

肝细胞生成素在睾丸组织中的相互作用蛋白

肝细胞生成素（HPO）具有复杂的生理功能,在睾丸中的高表达提示其在生殖活动中的重要性,而不仅局限于肝再生.构建了酵母表达载体pGBKT7-HPO,采用酵母双杂交系统,以HPO为诱饵蛋白,从人睾丸cDNA文库中寻找能够与HPO相互作用的蛋白质.经过筛选、验证阳性克隆,并进行PCR、测序和序列比对,得到4种相互作用蛋白质：NADH脱氢酶1、钠/钾ATP酶β3亚基、磷脂酶C δ1以及附睾分泌蛋白.提示HPO可能参与了细胞的蛋白质合成,能量代谢等.通过对候选蛋白的研究,为探讨HPO对睾丸组织细胞功能的调节机制提供了重要的线索.     

角质细胞生长因子-2与核糖体蛋白L22相互作用的发现及在哺乳动物细胞中的验证

通过聚合酶链式反应从人胎肝cDNA文库中钓取KGF-2 cDNA,构建诱饵蛋白载体pAS2-1-KGF-2并对其自身转录激活活性进行鉴定,利用酵母双杂交系统筛选人胎肝cDNA文库,挑选双阳性克隆.DNA序列分析和同源检索显示,所获侯选蛋白为人核糖体蛋白L22(RPL22).将KGF-2和侯选蛋白分别克隆至哺乳动物细胞双杂交的BD、AD质粒中,共同转染COS-7细胞,通过CAT分析验证了KGF-2和侯选蛋白之间的相互作用.为阐明KGF-2作用的分子机制提供有益线索.     

人分化相关基因Ndr2的克隆与组织表达谱研究

人Ndr1基因参与细胞终末分化 ,并且对肿瘤细胞增殖和肿瘤转移具有抑制作用 .从人 2 2周孕龄胎肝cDNA文库中获得与人Ndr1基因同源的一段表达性序列标签 ,继而从成人脑cDNA文库分离出其全长cDNA(2 12 1bp) ,并将该基因命名为Ndr2 .其染色体定位为 14q11 1- 11 2 ,开放阅读框编码 371个氨基酸 ,且与NDR1蛋白一样 ,含有一个典型的α β水解酶折叠类结构域 (α βhydrolasefold) .Northern杂交和点杂交分析显示 ,该基因与Ndr1一样 ,在脑中高表达 ,在胚胎组织的表达较低 ,在 8种人肿瘤细胞中的表达极低 .然而 ,Ndr2基因的组织表达谱与Ndr1又有鲜明的差异 :其在成人骨骼肌和脑等神经组织中表达最高 ,在唾液腺、肝、肾、心肌和气管中的表达次之 .结果提示 ,NDR2具有与NDR1相似或相关的重要功能 .     

脑红蛋白与Na^＋，K^＋-ATP酶β2亚基的相互作用及作用位点的鉴定

为研究神经系统特异性携氧蛋白———脑红蛋白 (NGB)保护神经元耐受缺氧损伤的分子机制 ,利用酵母双杂交系统从人胎脑cDNA文库中筛选与其有相互作用的蛋白质。序列分析表明 ,其中一个克隆的编码产物与Na ,K ATP酶 β2亚基 (NKA1b2 )序列一致。随后采用PCR方法从人胎脑cDNA文库中扩增获得NKA1b2全长cDNA。蛋白质结合实验表明 ,原核表达的NGB与体外转录翻译得到的NKA1b2在细胞外有结合作用。免疫共沉淀实验证明二者在生理条件下能够以复合物的形式存在。利用NGB系列短截体研究相互作用的位点发现 ,NGB蛋白N末端 1～ 75位氨基酸可与NKA1b2结合 ,但结合力很弱 ,而其C末端 75个氨基酸则与NKA1b2无结合作用 ,由此推测NGB蛋白整体的三维结构是结合所必需的。     

人胎肝唾液酸转移酶基因的克隆及测序*

根据已克隆的唾液酸转移酶的保守区的序列,以人胎肝mRNA为模板扩增出150bp的片段并测序。其中一个片段(s38)与已克隆的唾液酸转移酶的活性中心有57％～97％的同源性。根据s38的序列合成寡核苷酸并标记后用作探针筛选人胎肝cDNA文库。从文库中分离了一个编码α2,3－唾液酸转移酶的cDNA。该cDNA序列含一个编码340个氨基酸的开放读框,推导的氨基酸序列与人颌下腺(Galβ1,GalNAc。Α2,3－唾液酸转移酶相同,与猪颌下腺α2,3－唾液酸转移酶有83.2％的同源性。表明从人胎肝cDNA文库中分离的cDNA所编码的蛋白为Galβ1,3GalNAcα2,3－唾液酸转移酶。     

用表达性差异显示分析技术分离人胎肝组织选择性表达基因

目的：建立4月龄人胎肝组织选择性表达基因EST库,为研究胚胎肝组织特异表达基因提供有力的工具。方法：采用表达性差异显示分析（representational difference analysis,RDA) 技术建立4月龄人胎肝组织选择性表达基因EST库,并测定部分克隆核苷酸序列,以竞争PCR检测代表性基因的差异表达。结果与结论：以珠蛋白家族基因为标志,所建差减cDNA文库中α－珠蛋白家族基因的表达频率较未差减cDNA文库增高7倍,同时该文库也含有多种与肝生长密切相关的基因,表明RDA技术确是研究差异表达基因的有效手段,所建EST库富集胎肝特异表达基因。部分克隆序列分析获得2种未报道序列,其中一株含有丝／苏氨酸激酶结构域,表明可望从此库中分离具有重要未知功能的新基因。     

外显子捕获法分离FRAXA位点的新表达序列

外显子捕获是近年发展起来的一种自基因组DNA分离表达序列的有效方法.我们采用以pSPL3为剪接载体的外显子捕获系统,从覆盖FRAXA位点的酵母人工染色体YAC209G4中分离到2个新外显子序列A91和D12.A91在人胎肝和骨骼肌文库中丰度较高,在肝、肾和骨髓文库中也有PCR扩增.而D12在所分析的8个cDNA文库中均未见PCR扩增产物.从骨骼肌文库中克隆到一段包含A91的315 bp的cDNA(AM4470).多种组织RNA印迹显示,AM4470与骨骼肌和心脏mRNA杂交,转录本长度均为2.8 kb.     

RAI——一候选的人肺腺癌分化相关基因

通过进一步分析采用全反式维甲酸(all trans retinoic acid,ATRA)诱导人肺腺癌GLC-82细胞,经cDNA文库消减杂交构建的cDNA消减文库,得到一在ATRA诱导GLC-82细胞分化过程中激活表达(retinoic acid induced,RAI)的基因的cDNA片段,应用菌落原位杂交技术在胎脑cDNA文库中进行筛选,克隆RAI的全长cDNA序列并测序.RT-PCR分析表明,RAI在多种胎儿组织中表达.结果表明,RAI可能与细胞分化有关,并在细胞基本生命活动中发挥重要作用.     

胞红蛋白酵母双杂交载体的构建与表达

胞红蛋白（CGB）是一种新发现的分布于胞浆与胞核的携氧珠蛋白。为探讨CGB在体内的相互作用蛋白,从而促进对其分子调控网络的认识,根据CGB基因的开放阅读框架设计并合成PCR引物,从人胎肝cDNA文库中扩增得到该基因编码区.测序分析正确后将其定向克隆到酵母表达载体pGBKT7中,构建获得CGB的酵母表达载体pGBKT7-CGB,并在酵母菌AH109中表达。提取酵母总蛋白并利用标签蛋白（myc）的抗体进行免疫印迹检测。结果表明所构建的CGB酵母表达载体能够在酵母中高效表达,可用于后续的酵母双杂交文库的筛选工作。     

Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell

Macrophage migration inhibitory factor (MIF) is a pluripotent cytokine involved in inflammation and immune responses as well as in growth factor-dependent cell proliferation, cell cycle, angiogenesis, and tumorigenesis. Several studies have documented MIF expression in the sera following hepatic resection or in the course of liver cancer progression, but there is a paucity of information regarding the effect of MIF on hepatoma cells and relating mechanisms. In this paper, by [3H] thymidine incorporation, we found that exogenously added MIF could promote the proliferation of HepG2 in a dose-dependent manner. Hepatopoietin (HPO), as a liver-specific regeneration augmenter, could be induced by the expression of MIF in hepatoma cells. The activity of HPO promoter was increased, and its levels were enhanced after MIF was overexpressed in hepatoma cells. The similarities between HPO and MIF in structure and action led us to investigate their interaction and the inducing biological significance. Using yeast two-hybrid identification, we found that HPO interacted with MIF in yeast cells, and their binding ability was higher than that between HPO and JAB1 (Jun activation domain binding protein) or MIF and JAB1 in yeast cells. Their interaction was further verified by His pull-down assay in vitro and coimmunoprecipitation experiment in vivo. They were colocalized in the cytoplasm. Both HPO and MIF could bind to JAB1 and modulate the AP-1 pathway. When HPO and MIF were cotransfected into HepG2 cells, the binding activity of MIF to JAB1 was reduced, and the activity of AP-1 was improved. In contrast, MIF overexpressed in HepG2 was unable to interfere with the binding activity of HPO to JAB1, but its potentiation on AP-1 activity was reduced significantly. Taken together, these results indicate that MIF plays an important role in the proliferation of hepatoma cells, and the effect of MIF is in concert with HPO.     

The potentiation role of hepatopoietin on activator protein-1 is dependent on its sulfhydryl oxidase activity

Hepatopoietin (HPO) is a novel hepatotrophic growth factor that stimulates hepatocyte proliferation by two pathways. In the first, intracellular HPO specifically modulates the activator protein-1 (AP-1) pathway through JAB1 (Jun activation domain-binding protein 1), whereas in the second, extracellular HPO triggers the mitogen-activated protein kinase pathway by binding its specific receptor on the cell surface. In this report we demonstrate that HPO is a flavin-linked sulfhydryl oxidase, and the invariant CXXC (Cys-Xaa-Xaa-Cys) motif in HPO is essential for the enzyme activity of HPO but not for its dimerization nor for its binding ability with JAB1. Two intramolecular disulfides were identified in HPO by mass spectrometry, one of which is formed by the redox CXXC cysteine residues. HPO site-directed mutants (Cys/Ser) at active sites, which lost sulfhydryl oxidase activity, could not increase c-Jun phosphorylation and failed to potentiate JAB1-mediated AP-1 activation. However, the mutants still have mitogenic stimulation and mitogen-activated protein kinase activation effects on HepG2 cells. Thus, it can be concluded that the potentiation role of HPO on AP-1 is dependent on its sulfhydryl oxidase activity.     

Hepatopoietin interacts directly with COP9 signalosome and regulates AP-1 activity

Hepatopoietin (HPO)/augmenter of liver regeneration (ALR) is a specific hepatotrophic growth factor, which plays a key role in liver regeneration. Our previous study indicated that HPO executes its function by an inter-reactive network of the autocrine, paracrine and endocrine pathways. Recently, we have demonstrated that intracellular HPO interacts with Jun activation domain-binding protein 1 (JAB1) and leads to potentiation of activating protein-1 (AP-1) activity in a MAPK independent fashion. JAB1 is the fifth subunit of the COP9 signalosome (CSN), which is first identified as a suppressor of plant morphogenesis. A protein complex kinase activity associated with the CSN has been reported but not identified yet. In this report, we investigated further the association of HPO with the whole CSN. HPO exists in a complex with the eight-component CSN, both when purified from glycerol gradient centrifugation and when reciprocal immunoprecipitated from the lysates of transfected COS-7 cells. Intracellular HPO colocalizes with endogenous CSN in nucleus of hepatic cells. In addition, intracellular function of HPO that increases the phosphorylation of c-Jun leading to potentiate the AP-1 activity is inhibited by curcumin, a potent inhibitor of CSN-associated kinase. Taken together, these results elucidate a novel relationship of intracellular growth factor, HPO with large protein complex, CSN, which suggests a possible linkage between CSN and liver regeneration.     

Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif

Macrophage migration inhibitory factor (MIF) binds to c-Jun activation domain binding protein-1 (JAB1)/subunit 5 of COP9 signalosome (CSN5) and modulates cell signaling and the cell cycle through JAB1. The binding domain of JAB1 responsible for binding to MIF is unknown. We hypothesized that the conserved Mpr1p Pad1p N-terminal (MPN) domain of JAB1 may mediate binding to MIF. In fact, yeast two hybrid (YTH) and in vitro translation/coimmunoprecipitation (CoIP) analysis showed that a core MPN domain, which did not cover the functional JAB1/MPN/Mov34 metalloenzyme (JAMM) deneddylase sequence, binds to MIF comparable to full-length JAB1. YTH and pull-down analysis in conjunction with nanobead affinity matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry demonstrated that MIF(50-65) and MPN are sufficient to mediate MIF-JAB1 interaction, respectively. Finally, endogenous CoIP of MIF-CSN6 complexes from mammalian cells demonstrated that MPN is responsible for MIF-JAB1 binding in vivo, and, as CSN6 does not contain a functional JAMM motif, confirmed that the interaction does not require JAMM.     

JAB1 accelerates mitochondrial apoptosis by interaction with proapoptotic BclGs

The Bcl-2 family of proteins is the key regulators of cell apoptosis at the mitochondria level. The BH3-only pro-apoptotic member BclGs was unique among the family due to its highly specific expression in human testis and has been demonstrated to induce apoptosis dependent on the BH3 domain. However, the molecular mechanism of BclGs-induced apoptosis remains unclear. Here we show that overexpression of BclGs could induce Bax expression upregulation and translocation to mitochondria, cytochrome c release and activation of caspase-3. Moreover, we identified JAB1 as a novel BclGs-specific binding protein through a yeast two-hybrid screening in a human testis cDNA library. BclGs interacts with JAB1 both in vitro and in vivo. N-terminal region of BclGs (aa 1-67) was required for the interaction. Importantly, JAB1 and BclGs co-expression synergistically induces apoptosis. JAB1 could compete with Bcl-XL/Bcl-2 to bind to BclGs; thus, promote the apoptosis. RNAi-mediated knock-down of JAB1 results in the reduced proapoptotic activity of BclGs. Taken together, our results provided the first evidence that JAB1 is involved in the regulation of mitochondrial apoptotic pathway through specific interaction with BclGs.     

JAB1 participates in unfolded protein responses by association and dissociation with IRE1

Recent papers have reported that neuronal death in patients with Alzheimer's disease, Parkinson's disease, and cerebral ischemia has its origin in the endoplasmic reticulum (ER). IRE1alpha is one of the ER stress transducers that detect the accumulation of unfolded proteins in the ER. IRE1alpha mediates two major cellular responses, which are the unfolded protein response (UPR), a defensive response, and apoptosis that leads to cell death. However, little is known about the regulatory mechanisms that select between the UPR and apoptosis. We identified Jun activation domain-binding protein-1 (JAB1) as a molecule that interacts with IRE1alpha using a yeast two-hybrid system. We demonstrated that JAB1 binds to IRE1alpha in the absence of stress, but that binding is decreased by ER stress inducers. Moreover, mutant JAB1 down-regulates the UPR signaling pathway through tight binding with IRE1alpha. These results suggested that JAB1 may act as a key molecule in selecting the UPR or cell death by association and dissociation with IRE1alpha.     

JAB1/CSN5 and the COP9 signalosome. A complex situation

The Jun activating binding protein (JAB1) specifically stabilizes complexes of c-Jun or JunD with AP-1 sites, increasing the specificity of target gene activation by AP-1 proteins. JAB1 is also known as COP9 signalosome subunit 5 (CSN5), which is a component of the COP9 signalosome regulatory complex (CSN). Over the past year, JAB1/CSN5 has been implicated in numerous signaling pathways including those that regulate light signaling in plants, larval development in Drosophila, and integrin signaling, cell cycle control, and steroid hormone signaling in a number of systems. However, the general role of the CSN complex, and the specific role of JAB1/CSN5, still remain obscure. This review attempts to integrate the available data to help explain the role of JAB1/CSN5 and the COP9 signalosome in regulating multiple pathways (in this review, both JAB1 and CSN5 terminologies are used interchangeably, depending on the source material).